标题
Methods for actionable gene fusion detection in lung cancer: now and in the future
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 22, Issue 13, Pages 833-847
出版商
Future Medicine Ltd
发表日期
2021-09-16
DOI
10.2217/pgs-2021-0048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer
- (2021) Caterina De Luca et al. Cancers
- Genomic profiling in non-small-cell lung cancer in young patients. A systematic review
- (2021) D. Viñal et al. ESMO Open
- Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
- (2021) Justin F Gainor et al. LANCET ONCOLOGY
- Attenuated isolated 3’ signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC
- (2020) Gábor Smuk et al. LUNG CANCER
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
- (2020) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
- (2020) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients
- (2019) Caterina Fumagalli et al. Journal of Clinical Medicine
- Efficient ten-gene analysis of NSCLC tissue samples by next-generation sequencing
- (2019) Xiuhuan Ji et al. PATHOLOGY RESEARCH AND PRACTICE
- Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis
- (2019) Ruiying Zhao et al. Molecular Diagnosis & Therapy
- A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib
- (2019) You-cai Zhu et al. Clinical Lung Cancer
- Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns
- (2019) Sergi Clavé et al. Clinical Lung Cancer
- Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens
- (2019) Pasquale Pisapia et al. CANCER CYTOPATHOLOGY
- Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
- (2019) Natasha B. Leighl et al. CLINICAL CANCER RESEARCH
- Detection of NRG1 Gene Fusions in Solid Tumors
- (2019) Sushma Jonna et al. CLINICAL CANCER RESEARCH
- Testing algorithm for identification of patients with TRK fusion cancer
- (2019) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL PATHOLOGY
- Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer
- (2019) Chen Lin et al. LUNG CANCER
- MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities
- (2019) Lorenzo Nicolè et al. CANCER CYTOPATHOLOGY
- RET fusions in solid tumors
- (2019) Andrew Y. Li et al. CANCER TREATMENT REVIEWS
- Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
- (2018) N Guibert et al. ANNALS OF ONCOLOGY
- Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?
- (2018) Greta Alì et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- (2018) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
- (2018) D. Ross Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
- (2018) Igor Letovanec et al. Journal of Thoracic Oncology
- Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples
- (2018) Kurtis D. Davies et al. Journal of Thoracic Oncology
- Characteristics and Outcome of ROS1 -Positive Non–Small Cell Lung Cancer Patients in Routine Clinical Practice
- (2018) Sehhoon Park et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- (2018) Ming Sound Tsao et al. Journal of Thoracic Oncology
- ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
- (2018) Anne McLeer-Florin et al. LUNG CANCER
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma—a single center retrospective study
- (2018) Nadezda P. Velizheva et al. PATHOLOGY RESEARCH AND PRACTICE
- Response to ERBB3-Directed Targeted Therapy in NRG1 -Rearranged Cancers
- (2018) Alexander Drilon et al. Cancer Discovery
- Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression
- (2018) Domenico Trombetta et al. Oncotarget
- ALK- rearrangement in non-small-cell lung cancer (NSCLC)
- (2018) Xue Du et al. Thoracic Cancer
- Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study
- (2018) Cecily P. Vaughn et al. BMC CANCER
- Entrectinib Effective across NTRK Fusion–Positive Cancers
- (2018) Cancer Discovery
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases
- (2018) Anna Scattone et al. Translational Oncology
- Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study
- (2017) Roberta Sgariglia et al. JOURNAL OF CLINICAL PATHOLOGY
- ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma
- (2017) Lucia Anna Muscarella et al. Journal of Thoracic Oncology
- Lonely Driver ROS1
- (2017) Spasenija Savic et al. Journal of Thoracic Oncology
- Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions
- (2017) Nathan D. Gay et al. Journal of Thoracic Oncology
- Recent Advances in Targeting ROS1 in Lung Cancer
- (2017) Jessica J. Lin et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
- (2017) Fred R. Hirsch et al. Journal of Thoracic Oncology
- ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non–Small Cell Lung Cancer
- (2017) Jessica J. Lin et al. Journal of Thoracic Oncology
- First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
- (2017) Jean-Charles Soria et al. LANCET
- Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- (2017) Toyoaki Hida et al. LANCET
- Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
- (2017) Alison M. Schram et al. Nature Reviews Clinical Oncology
- Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
- (2017) Solange Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
- (2017) Kajsa Ericson Lindquist et al. Oncotarget
- Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
- (2017) Adriane F. Evangelista et al. BMC Pulmonary Medicine
- Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
- (2017) Toni-Maree Rogers et al. Scientific Reports
- Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches
- (2017) Julie A. Vendrell et al. Scientific Reports
- Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas
- (2016) Esther Conde et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
- (2016) Alexander Drilon et al. LANCET ONCOLOGY
- Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma
- (2016) Zhengbo Song et al. LUNG CANCER
- Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays
- (2016) Antonio Marchetti et al. LUNG CANCER
- Testing for ROS1 in non-small cell lung cancer: a review with recommendations
- (2016) Lukas Bubendorf et al. VIRCHOWS ARCHIV
- Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung
- (2016) Dong Hoon Shin et al. Oncotarget
- Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell
- (2016) Jing Zhao et al. Oncotarget
- ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma
- (2016) Sanja Dacic et al. Oncotarget
- MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
- (2016) Hyojin Kim et al. Oncotarget
- Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective
- (2015) E. Vigliar et al. CYTOPATHOLOGY
- The distribution ofBRAFgene fusions in solid tumors and response to targeted therapy
- (2015) Jeffrey S. Ross et al. INTERNATIONAL JOURNAL OF CANCER
- Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
- (2015) James Chih-Hsin Yang et al. LANCET ONCOLOGY
- microRNA classifiers are powerful diagnostic/prognostic tools inALK-,EGFR-, andKRAS-driven lung cancers
- (2015) Pierluigi Gasparini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing
- (2015) Saravana P. Selvanathan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TRK Inhibitor Shows Early Promise
- (2015) Cancer Discovery
- Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers
- (2015) Jin Sung Jang et al. Scientific Reports
- Clinicopathological characteristics and outcomes ofROS1-rearranged patients with lung adenocarcinoma withoutEGFR,KRASmutations andALKrearrangements
- (2015) Shafei Wu et al. Thoracic Cancer
- Landscape of gene fusions in epithelial cancers: seq and ye shall find
- (2015) Chandan Kumar-Sinha et al. Genome Medicine
- A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
- (2014) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
- (2014) Yunjian Pan et al. LUNG CANCER
- Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
- (2014) Seung Eun Lee et al. MODERN PATHOLOGY
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes
- (2014) Saravana M. Dhanasekaran et al. Nature Communications
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- CD74-NRG1 Fusions in Lung Adenocarcinoma
- (2014) L. Fernandez-Cuesta et al. Cancer Discovery
- ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas
- (2013) Lynette M. Sholl et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
- (2013) Aria Vaishnavi et al. NATURE MEDICINE
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of MicroRNAs in Archival Cytology Urine Smears
- (2013) Francesca Simonato et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer
- (2012) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- (2012) Doron Lipson et al. NATURE MEDICINE
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- Role and Relevance of TrkB Mutations and Expression in Non-Small Cell Lung Cancer
- (2011) T. Harada et al. CLINICAL CANCER RESEARCH
- An integrated semiconductor device enabling non-optical genome sequencing
- (2011) Jonathan M. Rothberg et al. NATURE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer
- (2010) Juliann Chmielecki et al. NUCLEIC ACIDS RESEARCH
- Chromosomal and genomic changes in lung cancer
- (2010) Marileila Varella-Garcia Cell Adhesion & Migration
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung
- (2008) Antonio Marchetti et al. HUMAN MUTATION
- EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
- (2008) Leah A. Owen et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started